好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, June 12, 2019

Large Study Finds Two Drugs that Prevent Seizures, Migraine Linked to Birth Defects

Increased Risk of Cleft Lip, Spina Bifida and More

MINNEAPOLIS -

Epilepsy drugs are not only prescribed to prevent seizures, they are increasingly prescribed for migraine, pain and psychiatric disorders such as bipolar disorder. But now a large study has confirmed that women who take either valproic acid or topiramate in the early months of pregnancy may have an increased risk of giving birth to a baby with birth defects. The study is published in the June 12, 2019, online issue of , the medical journal of the . 鈥淲hile these drugs can help prevent symptoms and improve a person鈥檚 quality of life, studies have raised serious concerns that some of these drugs may increase the risk of birth defects,鈥 said study author Rosemary Dray-Spira, MD, PhD, of the French National Agency for Medicines and Health Products Safety in Saint-Denis, France. 鈥淏ecause these drugs are being prescribed more widely, and because unplanned pregnancies are not uncommon, we wanted to examine their safety with a much larger study.鈥 For the study, researchers used French national health care databases containing data on nearly all pregnancies in the country. They identified more than 1.8 million pregnancies lasting five months or longer that ended in live births between January 2011 and March 2015. Among those pregnancies, researchers then identified women who were prescribed one of 10 seizure drugs from one month before pregnancy to within the first two months of the pregnancy. If they were taking more than one seizure drug, they were not included in the study. Researchers also examined the records of children born to these women, looking for 23 birth defects up to one or two years after birth, depending on the type of birth defect. Accounting for factors that could affect the risk of birth defects, such as age, folic acid supplementation and pre-gestational diabetes, researchers found that the women prescribed valproic acid had a 19 times greater risk of having a baby with spina bifida when compared to the women who did not take an epilepsy drug. Among the 913 women prescribed valproic acid, six babies had spina bifida, or 0.66 percent, compared to 616 babies of the 1,875,733 women who did not take an epilepsy drug, or 0.03 percent. Valproic acid also increased the risk of seven other birth defects including cleft palate and four types of heart defects. In addition, researchers found that women who were prescribed topiramate had a seven times greater risk of having a baby with cleft lip with or without cleft palate. Among the 517 women prescribed topiramate, three babies had cleft lip, or 0.60 percent compared to 1,637 babies of the more than 1.8 million women who did not take an epilepsy drug, or 0.09 percent. Researchers found no greater risk of birth defects associated with lamotrigine, levetiracetam, carbamazepine, oxcarbazepine and gabapentin. 鈥淥ur study not only confirmed what smaller studies have found, it also looked at a broader range of birth defects, contributing to a better and more complete understanding of the use of epilepsy drugs during pregnancy,鈥 said Dray-Spira. 鈥淭hese results may help guide doctors as they make prescribing decisions and look for alternative treatments for their patients who are of childbearing age.鈥 One limitation of the study was that the determination of epilepsy drug use was based on prescription records. Those records did not show whether a person actually took the medication. Learn more about epilepsy at , home of the 好色先生鈥檚 free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life on , and .

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life庐, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.


The 好色先生 is the leading voice in brain health. As the world鈥檚 largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN鈥檚 mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at or find us on , , , and .

For More Information*

Email media@aan.com

*While content of the 好色先生 (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver magazine website, .